CCN2 and cancer: In cancer, CTGF deregulation (ie overexpressed compared to low-expressing normal tissue or underexpressed compared to high-expressing normal tissue), was related to local and distant cancer progression, promoting proliferation, drug resistance, angiogenesis, adhesion, invasion and migration [112].